Critical Care Pharmacists: Improving Care by Increasing Access to Medication Expertise.

Authors:
Sikora A; Martin GS.

Journal:
Ann Am Thorac Soc

Publication Year: 2022

DOI:
10.1513/AnnalsATS.202206-502VP

PMCID:
PMC9667797

PMID:
35976863

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ann Am Thorac Soc

Abbreviation: Ann Am Thorac Soc

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Indoor Air Sources of Outdoor Air Pollution: Health Consequences, Policy, and Recommendations: An O…
Nassikas NJ; McCormack MC; Ewart G and 17 more (2024) - Transparency Score: 3/6
Providing Cleaning Recommendations for Positive Airway Pressure Devices.
Patel SR. (2024) - Transparency Score: 2/6
Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National…
Vaeli Zadeh A; Dinparastisaleh R; Vaezi A and 12 more (2024) - Transparency Score: 2/6
Statin Use and Reduced Risk of Pneumonia in Patients with Melioidosis: A Lung-Specific Statin Assoc…
Coston TD; Wright SW; Phunpang R and 15 more (2024) - Transparency Score: 3/6
Survival and Long-Term Functional Status of COVID-19 Patients Requiring Prolonged Extracorporeal Me…
Martínez-Martínez M; Schmidt M; Broman LM and 10 more (2024) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Author disclosures are available with the text of this article at www.atsjournals.org."

Evidence found in paper:

"Supported by AHRQ grant R21HS028485 (A.S.)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025